GMA161

· Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMA161, covering 2015-04-09 to 2015-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1]